Exercise may improve outcomes for patients with hematologic cancers
the ONA take:
A 12-week exercise rehabilitation program resulted in improvements in cancer-related fatigue and additional outcomes in patients with hematologic cancer following treatment, a new study published online ahead of print in the journal Supportive Care in Cancer has shown.
Because patients with hematologic malignancies exhibit significant physical deconditioning and psychological distress after treatment, researchers sought to evaluate the efficacy of a 12-week exercise rehabilitation on cancer-related fatigue and related outcomes in these patients following treatment.
Researchers enrolled 37 patients and randomly assigned them 1:1 to participate in the 12-week exercise rehabilitation or usual care.
The rehabilitation consisted of tailored exercise programs comprising aerobic and resistance exercises performed three times weekly for 12 weeks in local gyms and clinics. Those in the usual care group were offered a delayed, tailored 12-week exercise program after the initial study period.
The study demonstrated that the 12-week exercise rehabilitation program resulted in significant improvement in cancer-related fatigue, cardiovascular fitness, quality of life, muscle strength, and body composition. The delayed 12-week exercise program also showed similar significant improvements in patient outcomes.
A 12-week exercise rehabilitation program resulted in improvements in cancer-related fatigue.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- National Health Care Spending Expected to Grow Five Percent Annually
- Patients With Urologic Cancer Need Psycho-oncologic Support to Manage High Stress
- 1 Year of Adjuvant Trastuzumab Improves Long-Term DFS in Early Breast Cancer
- Lenalidomide Maintenance Appears Efficacious for Relapsed DLBCL
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|